Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 16 of 31
Impact of a Smartphone Application on Postpartum Weight Loss and Breastfeeding Rates Among Low-income, Urban Women
NCT03167073
Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments
NCT03211832
Neural Mechanisms of Mindfulness
NCT03466164
Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function
NCT03151239
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
NCT02907918
Communicating Multiple Disease Risks: A Translation of Risk Prediction Science
NCT03255291
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
NCT03007979
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
NCT03084536
Helping Poor Smokers Quit
NCT03194958
Alirocumab and Reverse Cholesterol Transport
NCT03014830
Implementation Intentions for Weight Loss and Dietary Change in College Students With Overweight and Obesity
NCT04105309
Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial
NCT03143569
CLA and Vitamin D on Protein Turnover
NCT03115775
Intervention to End Recurrent Unscheduled Bleeding Trial
NCT03118297
Food Effects on the Gut Microbiota
NCT03078283
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
NCT02995655
ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making)
NCT02929108
Exercise for People with Spinal Cord Injury
NCT04007445
N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
NCT03253328
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763
Scale Down for Endometrial Cancer
NCT03169023
Stepped Care for Depression in Heart Failure
NCT02997865
Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders
NCT02913222
Novel Anxiety Treatment
NCT03790696
Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
NCT02351180
Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary
NCT03262818
Compare Outcomes Between Two Acellular Dermal Matrices
NCT02891759
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies
NCT02950025
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
NCT02829268
Healthy Patients & Effect of Antibiotics
NCT03098485
Effect of Number of Remote Limb Ischemic Conditioning Cycles on Learning Enhancement
NCT03512041
Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
NCT02723448
BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
NCT02763384
Intubated ICU Patients
NCT02171091
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
NCT02891681
Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies
NCT03283670
Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells
NCT03118284
Reverse Shoulder Replacement: Age 60 or Younger Outcomes
NCT03148184
Sleep Quality and Amyloid-Beta Kinetics
NCT03077620
Anesthesiology Control Tower
NCT02830126
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
NCT02911935
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
NCT02974686
Optimizing Fall-risk Prediction in Older Adults With Cancer
NCT02912273
18F-FLT PET Imaging in Patients With Advanced Melanoma
NCT02891616
Nitrous Oxide Treatment for Tinnitus
NCT03365011
Intraoperative Fetal Heart Rate (FHR) Monitoring: a Feasibility Study
NCT02950896
Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
NCT02985515
Remifentanil in Adults With OSA
NCT02898792
DHEA in Synovial Sarcoma Patients
NCT02683148
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
NCT02669914
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.